St. Anna Kinderkrebsforschung
- Country
- 🇦🇹Austria
- Ownership
- -
- Established
- 1986-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
42
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (35 trials with phase data)• Click on a phase to view related trials
COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS)
- Conditions
- SARS-CoV-2 InfectionIntestinal InfectionCovid19
- First Posted Date
- 2021-09-24
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- St. Anna Kinderkrebsforschung
- Target Recruit Count
- 283
- Registration Number
- NCT05055466
- Locations
- 🇦🇹
St.Anna Children´s Hospital, Vienna, Austria(AUT), Austria
🇦🇹University Hospital Krems, Krems, Austria
🇦🇹University Hospital Tulln, Tulln, Austria
Allogeneic Stem Cell Transplantation for Children With CML
- Conditions
- Chronic Myeloid Leukemia
- Interventions
- Biological: bone marrow or peripheral blood stem cells
- First Posted Date
- 2016-03-14
- Last Posted Date
- 2021-04-15
- Lead Sponsor
- St. Anna Kinderkrebsforschung
- Target Recruit Count
- 13
- Registration Number
- NCT02707393
- Locations
- 🇦🇹
Universitätsklinik für Kinder- und Jugendheilkunde, Graz, Austria
🇦🇹St. Anna Kinderspital, Wien, Austria
🇨🇿Hospital Motol, Department of Pediatric Hematology and Oncology, BMT Unit, Praha, Czechia
Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation
- Conditions
- Cytomegalovirus InfectionAdenovirus Infection
- First Posted Date
- 2016-03-08
- Last Posted Date
- 2019-05-09
- Lead Sponsor
- St. Anna Kinderkrebsforschung
- Registration Number
- NCT02702427
- Locations
- 🇦🇹
St. Anna Children's Hospital, Vienna, Austria
Pre-existing Kinase Domain Mutations in Ph-positive Leukemias
- Conditions
- Leukemia
- First Posted Date
- 2015-12-31
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- St. Anna Kinderkrebsforschung
- Target Recruit Count
- 30
- Registration Number
- NCT02643888
- Locations
- 🇦🇹
Medical Universitiy of Vienna, Vienna, Austria
Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
- Conditions
- Systemic Mycosis
- First Posted Date
- 2015-07-08
- Last Posted Date
- 2021-01-12
- Lead Sponsor
- St. Anna Kinderkrebsforschung
- Target Recruit Count
- 244
- Registration Number
- NCT02492594
- Locations
- 🇦🇹
Medical University of Vienna, Department of Internal Medicine I, Vienna, Austria
🇦🇹Hospital Hietzing, Vienna, Austria
🇦🇹Hanusch Krankenhaus, Vienna, Austria
- Prev
- 1
- 2
- 3
- Next